Affinity Asset Advisors, LLC Rezolute, Inc. Transaction History
Affinity Asset Advisors, LLC
- $735 Million
- Q2 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,850,000 shares of RZLT stock, worth $8.57 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
1,850,000
Previous 1,600,000
15.63%
Holding current value
$8.57 Million
Previous $4.08 Million
95.02%
% of portfolio
1.08%
Previous 0.59%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
53Shares Held
39.3MCall Options Held
1KPut Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$52.2 Million0.12% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.99MShares$13.8 Million0.86% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13 Million1.78% of portfolio
-
Adar1 Capital Management, LLC Austin, TX2.06MShares$9.56 Million1.68% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.08 Million0.03% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $180M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...